Heather Cypher
Psychiatric/Mental Health · Hamilton, OHNPI 1033835772
Payments from drug & device makers
Across 363 payments — averaging $19.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$1K
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$723
- Johnson & Johnson$659
- Otsuka America Pharmaceutical, Inc.$445
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$371
- plus $2K from 14 others
What the payments were for
- Food & beverage$7,163100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 35 | $1,449 |
| AbbVie | 86 | $1,360 |
| Teva Pharmaceuticals USA, Inc. | 33 | $723 |
| Johnson & Johnson | 27 | $659 |
| Otsuka America Pharmaceutical, Inc. | 35 | $445 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $371 |
| Supernus Pharmaceuticals, Inc. | 11 | $358 |
| Alkermes, Inc. | 33 | $342 |
| Lundbeck LLC | 23 | $330 |
| Vanda Pharmaceuticals Inc. | 19 | $303 |
| Neurocrine Biosciences, Inc. | 12 | $262 |
| Idorsia Pharmaceuticals US Inc | 6 | $178 |
| Almatica Pharma LLC | 6 | $135 |
| Corium, LLC | 7 | $84 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Lilly USA, LLC | 2 | $34 |
| Novo Nordisk | 1 | $19 |
| Tris Pharma Inc | 1 | $14 |
| Sage Therapeutics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,178 in reported general payments places this provider in the 90th percentile of 1,808 psychiatric/mental health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $1,283 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 14 | $729 |
| Lorazepam | 11 | $36 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Hamilton
- Crystal TravisJackson$333K
- Kristina RoweIronton$253K
- Patricia SparksPortsmouth$210K
- Mary HallWarren$195K
- Kassandra KornbauCanfield$170K
- Terri PopovitzCincinnati$161K
- Steven MatesDayton$121K
- Robert ParsonsYoungstown$119K
- Chriscia BaneChillicothe$115K
- Rachael McLaughlinMaple Heights$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.